2024-12-01 2025-11-30 false Capium Accounts Production 1.1 14467991 2024-12-01 2025-11-30 14467991 bus:FullAccounts 2024-12-01 2025-11-30 14467991 bus:Micro-entities 2024-12-01 2025-11-30 14467991 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 14467991 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 14467991 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14467991 2024-12-01 2025-11-30 14467991 2025-11-30 14467991 bus:RegisteredOffice 2024-12-01 2025-11-30 14467991 core:WithinOneYear 2025-11-30 14467991 core:AfterOneYear 2025-11-30 14467991 1 2024-12-01 2025-11-30 14467991 bus:Director1 2024-12-01 2025-11-30 14467991 bus:Director1 2025-11-30 14467991 bus:Director1 2023-12-01 2024-11-30 14467991 2023-12-01 14467991 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 14467991 2023-12-01 2024-11-30 14467991 2024-11-30 14467991 core:WithinOneYear 2024-11-30 14467991 core:AfterOneYear 2024-11-30 14467991 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 14467991 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 14467991 bus:OrdinaryShareClass1 2025-11-30 14467991 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 14467991 bus:OrdinaryShareClass1 2024-11-30 14467991 core:MotorCars 2024-12-01 2025-11-30 14467991 core:MotorCars 2025-11-30 14467991 core:MotorCars 2024-11-30 14467991 core:ComputerEquipment 2024-12-01 2025-11-30 14467991 core:ComputerEquipment 2025-11-30 14467991 core:ComputerEquipment 2024-11-30 14467991 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 14467991 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-30 14467991 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 14467991 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 14467991 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 14467991 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 14467991 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 14467991 core:Non-currentFinancialInstruments 2025-11-30 14467991 core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14467991
England and Wales

 

 

 

DY HEALTH LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 December 2024

End date: 30 November 2025

DY Health Ltd
Contents Page
For the year ended 30 November 2025
Director Dr Dominic Yue
Registered Number 14467991
Registered Office 148 New Cavendish Street
Highwood House
London
W1W 6YH
Accountants P AND CO (PARTNERS) LLP
18 Ensign Street
London
E1 8PA
1
Director's report and financial statements
The directors present theirreport and accounts for the year ended 30 November 2025.
Principal activities
Principal activity of the company during the financial year was of medical consultancy
Directors
The directors who served the company throughout the year were as follows:
Jasmine Ho (from 07/11/2022 to 10/09/2025)
Dr Dominic Yue (from 01/10/2024)
Statement of directors' responsibilities
The directors are responsible for preparing the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (Financial Reporting Standard 105). The financial statements are required by law to give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
  • select suitable accounting policies and then apply them consistently
  • make judgements and estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.


The directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was approved by the board and signed on its behalf by:


----------------------------------
Dr Dominic Yue
Director

Date approved: 19 August 2026
2
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of DY Health Ltd for the year ended 30 November 2025 which comprise of the Income Statement, the Balance Sheet and the related notes from the companys accounting records and from information and explanations you have given us.


As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance


This report is made solely to the Board of Directors of DY Health Ltd , as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of DY Health Ltd and state those matters that we have agreed to state to the Board of Directors of DY Health Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DY Health Ltd and its Board of Directors as a body for our work or for this report.


It is your duty to ensure that DY Health Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of DY Health Ltd . You consider that DY Health Ltd is exempt from the statutory audit requirement for the year.


We have not been instructed to carry out an audit or a review of the accounts of DY Health Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.








....................................................

P AND CO (PARTNERS) LLP
18 Ensign Street
London
E1 8PA
20 August 2026
3
  30/11/2025   30/11/2024
    £ £   £ £
Fixed assets   4,627      2,504 
Current assets 414,628      208,913   
Prepayments and accrued income 2,638      138   
Creditors: amount falling due within one year (193,315)     (127,538)  
Net current assets   223,951      81,513 
Total assets less current liabilities   228,578      84,017 
Net assets   228,578      84,017 
 

         
Capital and reserves   228,578      84,017 
 
NOTES TO THE ACCOUNTS

General Information
DY Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 14467991, registration address 148 New Cavendish Street, Highwood House, London, W1W 6YH.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. 

The company's liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Current and deferred tax assets and liabilities are not discounted. 
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25% Reducing Balance
Computer Equipment 25% Reducing Balance
2.

Tangible fixed assets

Cost or valuation Motor Vehicles   Computer Equipment   Total
  £   £   £
At 01 December 2024 639    2,337    2,976 
Additions -    2,867    2,867 
Disposals -    -    - 
At 30 November 2025 639    5,204    5,843 
Depreciation
At 01 December 2024 44    428    472 
Charge for year 149    595    744 
On disposals -    -    - 
At 30 November 2025 193    1,023    1,216 
Net book values
Closing balance as at 30 November 2025 446    4,181    4,627 
Opening balance as at 01 December 2024 595    1,909    2,504 


3.

Average number of employees

Average number of employees during the year was 4 (2024 : 4).


For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 19 August 2026 and were signed on its behalf by:


--------------------------------
Dr Dominic Yue
Director
4